Overview
Status
Active
Registry date
2017-08-22
Share capital
5,000.00 PLN
Registered address
ul. Dukatów 10A, 31-431 Kraków, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 91 days late).
- 202526/06/2026
- 202405/04/2025
- 202326/06/2024
- 202229/06/2023
- 202114/10/2022
- 202009/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 102.96kMedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD 28.59kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 54.18kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 112.91kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Weronika Maria Haberage 52 – President of the Management Board
Manner of representation
The following is authorized to make declarations of will and sign documents on behalf of the company: 1. the President of the Management Board independently; 2. two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Weronika Maria Haberage 52 | 95 | $1,283.09 | 95% |
Others | 5 | $67.53 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-01-08.
22 1050 1445 1000 0024 3388 7565
70 1050 1445 1000 0090 8023 4066
92 1050 1445 1000 0090 8023 4058
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| SkinlabP.S.A. | $1,797,229.06 | skinlab.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org |
Change history
| Date | Event | |
|---|---|---|
| 2021-03-01 | Address change (Ul. Stefana Garczyńskiego 17/2, 31-524, Kraków → Ul. Dukatów 10a, 31-431, Kraków) | |
| 2019-04-25 | Name change (Perio3 → H&g) | |
| 2018-12-28 | Name change (Perio3 Spółka Z Ograniczoną Odpowiedzilnością → Perio3) | |
| 2017-08-22 | Entered in the register |
FAQ
The main business activity of H&G focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 22, 2017.
The headquarters is located at: ul. Dukatów 10A, 31-431 Kraków.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $99,292 in 2024, which is an increase of 13.9% compared to 2023.
Yes, the company recorded a net profit of $45,916 in 2024, meaning the company increased its profit by 125.1%.
The largest operating cost category falls under other operating costs. This category amounted to $40,959 in 2024, representing 83% of all operating expenses.
Last updated: 2026-07-10